Success stories Archive - Page 28 sur 45 - Prestwick Chemical Libraries

success-story

Success Stories


Publications
Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?

Tuberculosis

Goldman RC
Tuberculosis - vol. 93 569-588 (2013)

High through put screening (HTS) was extensively used in attempts to discover new TB drugs from libraries of pure small molecule compounds many of which complied with the rule of five. Coupled with new methods for determining the target of lead compounds by resistance selection followed by genome sequencing, screening for growth inhibitors led to […]

Publications
NIH Public Access

J Biomol Screen

Hutchinson D, Ho V, Dodd M, Dawson HN, Zumwalt AC, Colton CA
- vol. 148 825-832 (2008)

Publications
Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.

The open microbiology journal

Kourtesi C, Ball AR, Huang Y, Jachak SM, Vera DMA, Khondkar P, Gibbons S, Hamblin MR, Tegos GP
The open microbiology journal - vol. 7 34-52 (2013)

Conventional antimicrobials are increasingly ineffective due to the emergence of multidrug-resistance among pathogenic microorganisms. The need to overcome these deficiencies has triggered exploration for novel and unconventional approaches to controlling microbial infections. Multidrug efflux systems (MES) have been a profound obstacle in the successful deployment of antimicrobials. The discovery of small molecule efflux system blockers […]

Publications
A Novel Application of Furazolidone: Anti-Leukemic Activity in Acute Myeloid Leukemia

PLoS ONE

Jiang X, Sun L, Qiu JJ, Sun X, Li S, Wang X, So CWE, Dong S
PLoS ONE - vol. 8 1-9 (2013)

Acute myeloid leukemia (AML) is the most common malignant myeloid disorder of progenitor cells in myeloid hematopoiesis and exemplifies a genetically heterogeneous disease. The patients with AML also show a heterogeneous response to therapy. Although all-trans retinoic acid (ATRA) has been successfully introduced to treat acute promyelocytic leukemia (APL), it is rather ineffective in non-APL […]

Publications
Drug repurposing in pediatrics and pediatric hematology oncology

Drug Discovery Today

Blatt J, Corey SJ
Drug Discovery Today - vol. 18 4-10 (2013)

Drug ‘repurposing’, that is, using old drugs for new indications, has been proposed as a more efficient strategy for drug development than the current standard of beginning with novel agents. In this review, we explore the scope of drug repurposing in pediatric hematology oncology and in pediatrics in general. Drugs commonly used in children were […]

Publications
Agents that stabilize mutated von Hippel-Lindau (VHL) protein: results of a high-throughput screen to identify compounds that modulate VHL proteostasis.

Journal of biomolecular screening

Ding Z, German P, Bai S, Feng Z, Gao M, Si W, Sobieski MM, Stephan CC, Mills GB, Jonasch E
Journal of biomolecular screening - vol. 17 572-580 (2012)

Von Hippel-Lindau (VHL) disease is an autosomal dominant disorder that affects multiple organs. Treatment is mainly surgical, and effective systemic therapies are needed. We developed a cell-based screening tool to identify compounds that stabilize or upregulate full-length, point-mutated VHL protein. The 786-0 cell line was infected with full-length W117A-mutated VHL linked to a C-terminal Venus […]

Publications
Identification of new snake venom metalloproteinase inhibitors using compound screening and rational peptide design

ACS Medicinal Chemistry Letters

Villalta-Romero F, Gortat A, Herrera AE, Arguedas R, Quesada J, De Melo RL, Calvete JJ, Montero M, Murillo R, Rucavado A, Gutiérrez JM, Pérez-Payá E
ACS Medicinal Chemistry Letters - vol. 3 540-543 (2012)

The majority of snakebite envenomations in Central America are caused by the viperid species Bothrops asper, whose venom contains a high proportion of zinc-dependent metalloproteinases that play a relevant role in the pathogenesis of hemorrhage characteristic of these envenomations. Broad metalloproteinase inhibitors, such as the peptidomimetic hydroxamate Batimastat, have been shown to inhibit snake venom […]

Publications
Screening approaches to generating STAT inhibitors: Allowing the hits to identify the targets.

Jak-Stat

Walker SR, Frank DA
Jak-Stat - vol. 1 292-299 (2012)

STAT transcription factors are regulators of critical cellular processes such as proliferation, survival, and self-renewal. While the activity of these proteins is tightly regulated under physiological conditions, they can become constitutively activated in a broad range of human cancers. This inappropriate STAT activation leads to enhanced transcription of genes that can directly lead to the […]

Publications
Validation of surface plasmon resonance screening of a diverse chemical library for the discovery of protein tyrosine phosphatase 1b binders

Analytical Biochemistry

Zeder-Lutz G, Choulier L, Besse M, Cousido-Siah A, Figueras FXR, Didier B, Jung ML, Podjarny A, Altschuh D
Analytical Biochemistry - vol. 421 417-427 (2012)

We investigated the suitability of surface plasmon resonance (SPR) for providing quantitative binding information from direct screening of a chemical library on protein tyrosine phosphatase 1b (PTP1B). The experimental design was established from simulations to detect binding with K D < 10 -4 M. The 1120 compounds (cpds) were injected sequentially at concentrations [C(cpd)] of […]

Publications
Glucocorticoid compounds modify smoothened localization and hedgehog pathway activity

Chemistry and Biology

Wang Y, Davidow L, Arvanites AC, Blanchard J, Lam K, Xu K, Oza V, Yoo JW, Ng JMY, Curran T, Rubin LL, McMahon AP
Chemistry and Biology - vol. 19 972-982 (2012)

The Hedgehog signaling pathway is linked to a variety of diseases, notably a range of cancers. The first generation of drug screens identified Smoothened (Smo), a membrane protein essential for signaling, as an attractive drug target. Smo localizes to the primary cilium upon pathway activation, and this transition is critical for the response to Hedgehog […]